← SynDRA
MK-2894
SynDRA canonical compound SYN0049583 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PTGER4 |
|---|
| Mechanism of action | prostanoid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER4 ANTAGONIST
- prostanoid receptor antagonist
- prostaglandin inhibitor
Cross-references
Synonyms
- CHEMBL597997
- MK2894
- EP4 antagonists (inflammatory pain)
- L-161982
- MF-310
- MF-498
- MF-592
- MF-766
- EP4 antagonists (inflammatory pain), Merck Frosst Canada
- Prostaglandin E2 subtype 4 receptor antagonists (pain/inflammation), Merck Frosst
- RefChem:159193
- DTXCID20598813
- C25H22F3NO3S
- CS-0679
- GTPL4041
- orb1709116
- SCHEMBL2351863
- GLXC-04091
- EX-A5548
- BDBM50308131
- MFCD18251427
- AKOS030526193
- EBC-515463
- NCGC00379051-02
- FM103237
- HY-10413
- MK-2894?
- MS-28772
- DB-218696
- F84820
- T12061
- BRD-K27983781-001-01-4
- MK 2894
- 4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid
Look up MK-2894 in the interactive SynDRA portal →